D William Molloy
Overview
Explore the profile of D William Molloy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OCaoimh R, Foley M, Timmons S, Molloy D
J Alzheimers Dis Rep
. 2024 Aug;
8(1):971-980.
PMID: 39114555
Background: The Montreal Cognitive Assessment (MoCA) is recommended by the Movement Disorder Society for cognitive testing in movement disorders including Parkinson's disease (PD) and lewy body dementia. Few studies have...
2.
Clarnette R, Kostov I, Ryan J, Svendrovski A, Molloy D, OCaoimh R
Healthcare (Basel)
. 2024 Jul;
12(13).
PMID: 38998873
Understanding risk factors for frailty, functional decline and incidence of adverse healthcare outcomes amongst community-dwelling older adults is important to plan population-level health and social care services. We examined variables...
3.
OCaoimh R, Molloy D
J Alzheimers Dis Rep
. 2023 May;
7(1):299-306.
PMID: 37220615
Background: Short cognitive screening instruments (CSI) are required to identify cognitive impairment in busy outpatient clinics. While the Six Item Cognitive Impairment Test (6CIT) is commonly used, its accuracy in...
4.
OCaoimh R, Coghlan P, ODonovan M, Mohd Zaki N, Daly B, Gao Y, et al.
J Alzheimers Dis
. 2022 Sep;
90(4):1417-1427.
PMID: 36057819
Background: Self or home-administered cognitive screening instruments (CSIs) can reduce barriers to the early detection of mild cognitive impairment (MCI) and dementia. Objective: To examine the acceptability and diagnostic accuracy...
5.
OCaoimh R, Calnan M, Dhar A, Molloy D
J Alzheimers Dis Rep
. 2021 Nov;
5(1):739-747.
PMID: 34755048
Background: Although caregiver burden is common among carers of people with dementia, little is known about its prevalence and predictors among caregivers of patients attending memory clinics. Objective: To examine...
6.
Messinis L, ODonovan M, Molloy D, Mougias A, Nasios G, Papathanasopoulos P, et al.
Arch Clin Neuropsychol
. 2021 Apr;
36(5):858.
PMID: 33930106
No abstract available.
7.
Xu Y, Yi L, Lin Y, Peng S, Wang W, Lin W, et al.
Front Neurol
. 2021 Mar;
12:608188.
PMID: 33763012
Screening for post-stroke cognitive impairment (PSCI) is necessary because stroke increases the incidence of and accelerates premorbid cognitive decline. The Quick Mild Cognitive Impairment (Q) screen is a short, reliable...
8.
Tziraki C, Grimes C, Ventura F, OCaoimh R, Santana S, Zavagli V, et al.
Prim Health Care Res Dev
. 2020 Dec;
21:e60.
PMID: 33298200
No abstract available.
9.
OCaoimh R, Sezgin D, ODonovan M, Molloy D, Clegg A, Rockwood K, et al.
Age Ageing
. 2020 Oct;
50(1):96-104.
PMID: 33068107
Introduction: The prevalence of frailty at population level is unclear. We examined this in population-based studies, investigating sources of heterogeneity. Methods: PubMed, Embase, CINAHL and Cochrane Library databases were searched...
10.
Messinis L, ODonovan M, Molloy D, Mougias A, Nasios G, Papathanasopoulos P, et al.
Arch Clin Neuropsychol
. 2020 Aug;
36(4):578-586.
PMID: 32783063
Introduction: Short cognitive screening instruments (CSIs) are widely used to stratify patients presenting with cognitive symptoms. The Quick Mild Cognitive Impairment (Qmci) screen is a new, brief (<5mins) CSI designed...